Access this stock data via API
Subscribe
Genmab A/S
0
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 3.0B 16.5B 14.5B 8.4B
Cost of revenue 137.4M 226M 0 0
Gross profit 2.9B 16.2B 14.5B 8.4B
Operating expense
Research & development 1.4B 7.6B 5.6B 4.2B
Selling general and admin 528.8M 3.3B 2.7B 1.3B
Other operating expenses
Operating income 977.0M 5.3B 6.3B 3.0B
Non operating interest income
Income 138.8M 939M 324M 197M
Expense 16.7M 27M 21M 13M
Other income expense 179.4M -596M 375M 781M
Pretax income 1.3B 5.6B 6.9B 3.9B
Tax provision 184.2M 1.3B 1.5B 961M
Net income 1.1B 4.4B 5.5B 3.0B
Basic EPS 17.1 66.6 84.5 46
Diluted EPS 16.9 66.0 83.7 45.5
Basic average shares 408.4M 65.3M 65.8M 65.6M
Diluted average shares 408.4M 65.3M 65.8M 65.6M
EBITDA 1.2B 6.6B 7.0B 3.4B
Net income from continuing op. 1.3B 5.6B 6.9B 3.9B
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 19 minutes

08:40
00:00
09:00
17:00
23:59

Trading Hours (Monday - Friday):

Main market
09:00 - 17:00
All times are displayed in the Europe/Copenhagen timezone (CET, UTC+01:00).